S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
U.S. and China Locked in an all-out Resource War! (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
U.S. and China Locked in an all-out Resource War! (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
U.S. and China Locked in an all-out Resource War! (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
U.S. and China Locked in an all-out Resource War! (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
U.S. and China Locked in an all-out Resource War! (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
U.S. and China Locked in an all-out Resource War! (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
U.S. and China Locked in an all-out Resource War! (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
U.S. and China Locked in an all-out Resource War! (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
U.S. and China Locked in an all-out Resource War! (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
U.S. and China Locked in an all-out Resource War! (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
U.S. and China Locked in an all-out Resource War! (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
U.S. and China Locked in an all-out Resource War! (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
NASDAQ:APDN

Applied DNA Sciences - APDN Stock Forecast, Price & News

$1.37
-0.01 (-0.72%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.35
$1.39
50-Day Range
$1.12
$2.82
52-Week Range
$0.62
$7.35
Volume
91,578 shs
Average Volume
157,847 shs
Market Capitalization
$16.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Applied DNA Sciences MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
410.9% Upside
$7.00 Price Target
Short Interest
Healthy
8.25% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Applied DNA Sciences in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.43) to ($0.83) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Industrial Products Sector

162nd out of 183 stocks

Miscellaneous Business Services Industry

5th out of 6 stocks

APDN stock logo

About Applied DNA Sciences (NASDAQ:APDN) Stock

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Stock News Headlines

Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
APDN Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN)
Applied DNA Launches Monkeypox Testing Service
See More Headlines
Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

APDN Company Calendar

Last Earnings
8/11/2021
Today
11/30/2022
Next Earnings (Estimated)
12/08/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Miscellaneous business services
Sub-Industry
N/A
Current Symbol
NASDAQ:APDN
Employees
78
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+410.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-68.79%

Debt

Sales & Book Value

Annual Sales
$9.03 million
Book Value
$1.48 per share

Miscellaneous

Free Float
11,220,000
Market Cap
$16.41 million
Optionable
Optionable
Beta
0.71

Key Executives

  • Dr. James A. Hayward Ph.D. (Age 68)
    Sc.D., Chairman, Pres & CEO
    Comp: $984.84k
  • Ms. Beth M. Jantzen CPA (Age 46)
    CPA, Chief Financial Officer
    Comp: $278.85k
  • Ms. Judith Murrah (Age 64)
    COO & Sec.
    Comp: $314.42k
  • Mr. Sanjay M. Hurry
    Exec. Director of Investor Relations & Corp. Communications
  • Mr. Clay Shorrock Esq. (Age 37)
    J.D., Chief Legal Officer & Exec. Director of Bus. Devel.
  • Mr. John Shearman
    Exec. Director of Marketing & Cannabis Bus.
  • Mr. Tony Benson
    Managing Director of EMEA
  • Ms. Janice Meraglia
    VP, Gov. & Military Programs
  • Ms. MeiLin Wan
    VP of Textile Sales
  • Dr. Stephen Hughes
    Director of DNA Programs













APDN Stock - Frequently Asked Questions

What is Applied DNA Sciences' stock price forecast for 2023?

0 Wall Street research analysts have issued 12 month price objectives for Applied DNA Sciences' shares. Their APDN share price forecasts range from $6.00 to $8.00. On average, they predict the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 410.9% from the stock's current price.
View analysts price targets for APDN
or view top-rated stocks among Wall Street analysts.

How have APDN shares performed in 2022?

Applied DNA Sciences' stock was trading at $4.02 on January 1st, 2022. Since then, APDN shares have decreased by 65.9% and is now trading at $1.37.
View the best growth stocks for 2022 here
.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a decrease in short interest in November. As of November 15th, there was short interest totaling 988,000 shares, a decrease of 23.4% from the October 31st total of 1,290,000 shares. Based on an average daily volume of 2,920,000 shares, the days-to-cover ratio is currently 0.3 days.
View Applied DNA Sciences' Short Interest
.

When is Applied DNA Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 8th 2022.
View our APDN earnings forecast
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) posted its quarterly earnings results on Wednesday, August, 11th. The technology company reported ($0.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.20. The technology company earned $1.70 million during the quarter, compared to analysts' expectations of $3.44 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 158.37% and a negative net margin of 68.79%.

What is James A. Hayward's approval rating as Applied DNA Sciences' CEO?

2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend.

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.95%), Citadel Advisors LLC (0.00%), Two Sigma Investments LP (1.08%), BlackRock Inc. (0.85%), State Street Corp (0.63%) and Cutler Group LLC CA (0.00%).
View institutional ownership trends
.

How do I buy shares of Applied DNA Sciences?

Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $1.37.

How much money does Applied DNA Sciences make?

Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $16.41 million and generates $9.03 million in revenue each year. The technology company earns $-14,290,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900.

This page (NASDAQ:APDN) was last updated on 11/30/2022 by MarketBeat.com Staff